Back to Search

DAN THEODORESCU, MD

MD

Urology Physician

NPI: 1336284249Individual

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

49199(CO)

Research & Publications (20)

Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics.
PMID 19229372·Curr Oncol·2009
8-other
Learning therapeutic lessons from metastasis suppressor proteins.
PMID 19242414·Nat Rev Cancer·2009
6-review
Prediction of muscle-invasive bladder cancer using urinary proteomics.
PMID 19602546·Clin Cancer Res·2009
8-other
Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.
PMID 19564150·Mol Cell Proteomics·2009
8-other
Utilizing the molecular gateway: the path to personalized cancer management.
PMID 19246616·Clin Chem·2009
6-review
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.
PMID 19671741·Mol Cancer Ther·2009
7-preclinical
Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.
PMID 19321744·Proc Natl Acad Sci U S A·2009
8-other
Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.
PMID 19147813·Am J Pathol·2009
7-preclinical
The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
PMID 19597474·Oncogene·2009
7-preclinical
Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.
PMID 19107233·Neoplasia·2009
8-other
Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.
PMID 19276387·Cancer Res·2009
7-preclinical
Molecular credentialing of rodent bladder carcinogenesis models.
PMID 18670642·Neoplasia·2008
7-preclinical
Integrin agonists as adjuvants in chemotherapy for melanoma.
PMID 18829498·Clin Cancer Res·2008
7-preclinical
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer.
PMID 18373357·J Proteome Res·2008
8-other
Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis.
PMID 19468362·Indian J Urol·2008
8-other
Predicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.
PMID 18588455·Expert Rev Anticancer Ther·2008
6-review
Cryotherapy for prostate cancer: what we know, what we need to know.
PMID 18550127·J Urol·2008
8-other
Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
PMID 18386291·Prostate·2008
8-other
Invasion and metastasis models for studying RhoGDI2 in bladder cancer.
PMID 18374168·Methods Enzymol·2008
7-preclinical
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.
PMID 18724390·Oncogene·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
12605 E 16TH AVE
AURORA, CO 80045

Location

Practice Location

12605 E 16TH AVE, AURORA, CO
(720) 848-0000

Quick Facts

NPI
1336284249
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile